4//SEC Filing
PHARMATHENE, INC 4
Accession 0001144204-16-124773
$ALTCIK 0001326190operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:09 PM ET
Size
25.8 KB
Accession
0001144204-16-124773
Insider Transaction Report
Form 4
MACNEILL PHILIP
Controller and PAO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−14,063→ 4,687 totalExercise: $1.94Exp: 2024-01-29→ Common Stock (14,063 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−4,500→ 0 totalExercise: $1.21Exp: 2021-12-01→ Common Stock (4,500 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−5,625→ 0 totalExercise: $1.13Exp: 2022-12-03→ Common Stock (5,625 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−10,000→ 10,000 totalExercise: $1.71Exp: 2024-12-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.21/sh+4,500$5,445→ 54,500 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.21/sh+1,845$2,232→ 56,345 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.94/sh+14,063$27,282→ 76,033 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.71/sh+10,000$17,100→ 86,033 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.13/sh+5,625$6,356→ 61,970 total - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-09-20$1.66/sh+17,656$29,309→ 103,689 total - Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−1,845→ 0 totalExercise: $1.21From: 2012-12-01Exp: 2021-12-01→ Common Stock (1,845 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2016-09-20−17,656→ 52,969 totalExercise: $1.66Exp: 2025-12-03→ Common Stock (17,656 underlying)
Footnotes (5)
- [F1]These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 1, 2011.
- [F2]These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 3, 2012.
- [F3]These options became exercisable in 4 equal annual installments, with the first installment exercisable on January 29, 2014.
- [F4]These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.
- [F5]These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326190
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:09 PM ET
- Size
- 25.8 KB